VIDAS TOXO Competition Kit 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BioMerieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2016-08-10
  • 사례 출판 날짜
    2016-08-10
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomerieux vidas toxo competition kit medical device manufacturer, biomerieux, has issued a medical device safety alert concerning its vidas toxo competition kit [reference number: 30211; lot number: 1004666050; expiration date: 24 jan 2017]. the manufacturer received several complaints due to c2 control out of range on the affected product. due to this anomaly when the calibration is launched an alarm is triggered by the instrument. however, this alarm does not block the run and results are still provided. the investigation is on progress; however, the manufacturer has already highlighted that: the anomaly occurs randomly on certain kits of the impacted lot 1004666050, this result is linked to an increase of s1 standard’s rfv (relative fluorescence value) signal. considering the rfv signal increase of s1 standard, involving c2 control rfv signal decrease, the most probable hypothesis is the rfv signals will continue to evolve what could lead to block the calibration. according to the manufacturer, one positive control and one negative control are included in each vidas txc kit. these controls must be performed immediately after opening a new kit to ensure that reagent performance has not been altered. each calibration must also be checked using these controls. the instrument will only be able to check the control values if they are identified by c1 and c2. results cannot be validated if the control values deviate from the expected values. the expected negative control value must be included in the range indicated on the mle card. as the results cannot be validated there is no potential for false result. the potential hazard is to have delayed results. the manufacturer is advising users to discontinue use and discard any remaining inventory of the affected lot. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 10 august 2016.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BioMerieux VIDAS TOXO Competition Kit
  • Manufacturer

Manufacturer